Dyne Therapeutics Shares Decline After Pricing $375 Million Public Offering
Shares of Dyne Therapeutics (NASDAQ:DYN) fell by 9% after the company priced a public offering at a discount to its previous closing price. The offering is expected to raise approximately $375 million, with underwriters retaining an option for additional shares.
Tickers: $DYN